Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sokol V Todi

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Elife|February 16, 2022
Endurance exercise ameliorates phenotypes in <i>Drosophila</i> models of spinocerebellar ataxiasAlyson Sujkowski, Kristin Richardson, Matthew V Prifti, et al.
G3 (Bethesda, Md.)|August 8, 2023
Phenotypic defects from the expression of wild-type and pathogenic TATA-binding proteins in new Drosophila models of Spinocerebellar Ataxia Type 17Nikhil Patel, Nadir Alam, Kozeta Libohova, et al.
Fly|September 30, 2008
Cut mutant Drosophila auditory organs differentiate abnormally and degenerateDominic J S Ebacher, Sokol V Todi, Daniel F Eberl, et al.
Scientific Reports|June 2, 2018
Expression and Regulation of Deubiquitinase-Resistant, Unanchored Ubiquitin Chains in DrosophilaJessica R Blount, Kozeta Libohova, Gregory B Marsh, et al.
Frontiers in Neuroscience|February 3, 2023
Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in <i>Drosophila</i> models of Spinocerebellar Ataxia Type 3Matthew V Prifti, Kozeta Libohova, Autumn L Harris, et al.
Journal of Neuroscience Research|July 10, 2020
Degron capability of the hydrophobic C-terminus of the polyglutamine disease protein, ataxin-3Jessica R Blount, Sean L Johnson, Kozeta Libohova, et al.
The Journal of Biological Chemistry|April 30, 2013
JosD1, a membrane-targeted deubiquitinating enzyme, is activated by ubiquitination and regulates membrane dynamics, cell motility, and endocytosisTakahiro Seki, Lijie Gong, Aislinn J Williams, et al.
Frontiers in Molecular Neuroscience|October 3, 2022
A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseasesSean L Johnson, Wei-Ling Tsou, Matthew V Prifti, et al.
Scientific Reports|December 25, 2019
Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson's disease with dementiaDeepthi Yedlapudi, Liping Xu, Dan Luo, et al.
Biology Open|December 17, 2016
Polyglutamine length-dependent toxicity from α1ACT in Drosophila models of spinocerebellar ataxia type 6Wei-Ling Tsou, Sultan H Qiblawi, Ryan R Hosking, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Elife|February 16, 2022
Endurance exercise ameliorates phenotypes in <i>Drosophila</i> models of spinocerebellar ataxiasAlyson Sujkowski, Kristin Richardson, Matthew V Prifti, et al.
G3 (Bethesda, Md.)|August 8, 2023
Phenotypic defects from the expression of wild-type and pathogenic TATA-binding proteins in new Drosophila models of Spinocerebellar Ataxia Type 17Nikhil Patel, Nadir Alam, Kozeta Libohova, et al.
Fly|September 30, 2008
Cut mutant Drosophila auditory organs differentiate abnormally and degenerateDominic J S Ebacher, Sokol V Todi, Daniel F Eberl, et al.
Scientific Reports|June 2, 2018
Expression and Regulation of Deubiquitinase-Resistant, Unanchored Ubiquitin Chains in DrosophilaJessica R Blount, Kozeta Libohova, Gregory B Marsh, et al.
Frontiers in Neuroscience|February 3, 2023
Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in <i>Drosophila</i> models of Spinocerebellar Ataxia Type 3Matthew V Prifti, Kozeta Libohova, Autumn L Harris, et al.
Journal of Neuroscience Research|July 10, 2020
Degron capability of the hydrophobic C-terminus of the polyglutamine disease protein, ataxin-3Jessica R Blount, Sean L Johnson, Kozeta Libohova, et al.
The Journal of Biological Chemistry|April 30, 2013
JosD1, a membrane-targeted deubiquitinating enzyme, is activated by ubiquitination and regulates membrane dynamics, cell motility, and endocytosisTakahiro Seki, Lijie Gong, Aislinn J Williams, et al.
Frontiers in Molecular Neuroscience|October 3, 2022
A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseasesSean L Johnson, Wei-Ling Tsou, Matthew V Prifti, et al.
Scientific Reports|December 25, 2019
Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson's disease with dementiaDeepthi Yedlapudi, Liping Xu, Dan Luo, et al.
Biology Open|December 17, 2016
Polyglutamine length-dependent toxicity from α1ACT in Drosophila models of spinocerebellar ataxia type 6Wei-Ling Tsou, Sultan H Qiblawi, Ryan R Hosking, et al.
Pageof 8